Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity
Bochra Tourki(University of South Florida), Ganesh V. Halade(University of South Florida), Saame Raza Shaikh(University of North Carolina at Chapel Hill), Charles N. Serhan(Brigham and Women's Hospital), Xavier Leroy(Domain Therapeutics (France)), Vasundhara Kain(University of South Florida)
Cited by 23
Related Papers
Mitochondrial function as a therapeutic target in heart failure
|Nature Reviews Cardiology|2016|786
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
|Cell|2012|572
Lipid Mediators in the Resolution of Inflammation
|Cold Spring Harbor Perspectives in Biology|2014|549
Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
|British Journal of Pharmacology|2007|428